Mice lacking the transcription factor CIITA - A second look

International Immunology

Volumn 10, Issue 12, 1998, Pages 1957-1967

  Williams, G Stuart ^a   Malin, Mark ^b   Vremec, David ^c   Chang, Cheong Hee ^d   Boyd, Richard ^b   Benoist, Christophe ^a   Mathis, Diane ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b MONASH UNIVERSITY   (Australia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Dendritic cells; Gene expression; Gene targeting; MHC class II genes

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL LINE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STRUCTURAL GENE;

EID: 0031704329     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.12.1957     Document Type: Article

References (65)

1. Cosgrove, D., Gray, D., Dierich, A., Kaufman, J., Lemeur, M., Benoist, C. and Mathis, D. 1991. Mice lacking MHC class II molecules. Cell 66:1051.
2. + T cells in major histocompatibility complex class II-deficient mice. Science 253:1417.
3. Klein, C., Lisowska-Grospierre, B., Le Deist, F., Fischer, A. and Griscelli, C. 1993. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J. Pediatr. 123:921.
4. Mach, B., Steimle, V., Martinez-Soria, E. and Reith, W. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301.
5. Benoist, C. and Mathis, D. 1990. Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu. Rev. Immunol. 8:681.
6. Boss, J. M. 1997. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:107
7. Glimcher, L. H. and Kara, C. J. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:13.
8. Steimle, V., Otten, L. A., Zufferey, M. and Mach, B. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
9. Bradley, M. B., Fernandez, J. M., Ungers, G., Diaz-Barrientos, T., Steimle, V., Mach, B., O'Reilly, R. and Lee, J. S. 1997. Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA. J. Immunol. 159:1086.
10. Chang, C. H. and Flavell, R. A. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:765.
11. Chang, C. H., Hong, S. C., Hughes, C. C., Janeway, C. A. J. R. and Flavell. R. A. 1995. CIITA activates the expression of MHC class II genes in mouse T cells. Int. Immunol. 7:1515.
12. Martinez-Soria, E., Siegrist, C. A. and Mach, B. 1996. Highly efficient peptide binding and T cell activation by MHC class II molecules of CIITA-transfected cells. Int. Immunol. 8:543.
13. Steimle, V., Siegrist, C. A., Mottet, A., Lisowska-Grospierre, B. and Mach, B. 1994. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106.
14. Chin, K. C., Mao, C., Skinner, C., Riley, J. L., Wright, K. L., Moreno, C. S., Stark, G. R., Boss, J. M. and Ting, J. P. 1994. Molecular analysis of G1B and G3A IFN-gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1:687.
15. Kern, I., Steimle, V., Siegrist, C. A. and Mach, B. 1995. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Int. Immunol. 7:1295.
16. Gobin, S. J., Peijnenburg, A., Keijsers, V. and van den Elsen, P. J. 1997. Site alpha is crucial for two routes of IFN-gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 6:601.
17. Martin, B. K., Chin, K. C., Olsen, J. C., Skinner, C. A., Dey, A. Ozato, K. and Ting, J. P. 1997. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6:591.
18. Hobart, M., Ramassar, V., Goes, N., Urmson, J. and Halloran, P. F. 1997. IFN-regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J. Immunol. 158:4260.
19. Zhou, H. and Glimcher, L. H. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545.
20. Riley, J. L., Westerheide, S. D., Price, J. A. Brown J. A. and Boss, J. M. 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533.
21. Fontes, J. D., Jabrane-Ferrat, N. and Peterlin, B. M. 1997. Assembly of functional regulatory complexes on MHC class II promoters in vivo. J. Mol. Biol. 270:336.
22. Mahanta, S. K., Scholl, T., Yang, F. C. and Strominger, J. L. 1997. Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. Proc. Natl Acad. Sci. USA 94:6324.
23. Scholl, T., Stevens, M. B., Mahanta, S. and Strominger, J. L. 1996. A zinc finger protein that represses transcription of the human MHC class II gene, DPA. J. Immunol. 156:1448.
24. Abdulkadir, S. A., Krishna, S., Thanos, D., Maniatis, T., Strominger, J. L. and Ono, S. J. 1995, Functional reles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression. J. Exp. Med. 182:487.
25. Chang, C. H., Guerder, S., Hong, S. C., van Ewijk, W. and Flavell, R. A. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167.
26. Sims, T. N., Elliott, J. F., Ramassar, V., Denney, D. W., Jr and Halloran, P. F. 1997. Mouse class II transactivator: cDNA sequence and amino acid comparison with the human class II transactivator. Immunogenetics 45:220.
27. Schwartz, F., Maeda, N., Smithies, O., Hickey, R., Edelmann, W., Skoultchi, A. and Kucherlapati, R. 1991. A dominant positive and negative selectable gene for use in mammalian cells. Proc. Natl Acad. Sci. USA 88:10416.
28. Dupe, V., Davenne, M., Brocard, J., Dolle, P., Mark, M., Dierich, A., Chambon, P. and Rijli, F. M. 1997. In vivo functional analysis of the Hoxa-1 3′ retinoic acid response element (3′RARE). Development 124:399.
29. Vremec, D. and Shortman, K. 1997. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159:565.
30. Coffman, R. L. and Weissman, I. L. 1981. B220: a B cell-specific member of the T200 glycoprotein family. Nature 289:681.
31. Landais, D., Beck, B. N., Buerstedde, J.-M., Degraw, S., Klein, D., Koch, N., Murphy, D., Pierres, M., Tada, T., Yamamoto, K., Benoist, C. and Mathis, D. 1986. The assignment of chain specificities for anti-la monoclonal antibodies using L cell transfectants. J. Immunol. 137:3002.
32. Loken, M. and Stall, A. 1982. Flow cytometry as an analytical and preparative tool in immunology. Immunol. Methods 50:585.
33. Tomonari, K. 1988. A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex. Immunogenetics 28:455
34. Godfrey, D. I., Izon, D. J., Tucek, C. L., Wilson, T. J. and Boyd, R. L. 1990. The phenotypic heterogeneity of murine thymic stromal cells. Immunology 70:66.
35. Van Vliet, E., Melis, M. and van Ewijk, W. 1984. Monoclonal antibodies to stromal cell types of the mouse thymus. Eur. J. Immunol. 14:524.
36. Rouse, R., Bolin, L., Bender, J. and Kyewski, B. 1988. Monoclonal antibodies reactive with subsets of mouse and human thymic epithelial cells. J. Histochem. Cytochem. 36:1511.
37. Metlay, J., Witmer-Pack, M., Agger, R., Crowley, M., Lawless, D. and Steinman, R. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171:1753.
38. Naspetti, M., Aurrand-Lions, M., De Koning, J., Malissen, M., Galland, F., Lo, D. and Naquet, P. 1997. Thymocytes and RelB-dependent medullary epithelial cells provide growth-promoting and organization signals. respectively, to thymic medullary stromal cells. Eur. J. Immunol. 27:1392.
39. Chang, C. H., Fontes, J. D., Peterlin, M. and Flavell, R. A. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes J. Exp. Med. 180:1367.
40. Gu, H., Marth, J. D., Orban, P. C., Mossmann, H. and Rajewsky, K. 1994. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265:103.
41. Xu, Y., Davidson, L., Alt, F. W. and Baltimore, D. 1996. Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement. Immunity 4:377.
42. Artelt, P., Grannemann, R., Stocking, C., Friel, J., Bartsch, J. and Hauser, H. 1991. The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells. Gene 99:249.
43. Clausen, BE., Waldburger, JM., Schwenk, F., Barras, E., Mach, B., Rajewsky, K., Forster, I. and Reith, W. 1998. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity 8:143.
44. Rickert, R. C., Roes, J. and Rajewsky, K. 1997. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25:1317.
45. Douhan, J., Hauber, I., Eibl, M. M. and Glimcher, L. H. 1996. Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains. J. Exp. Med. 183:1063.
46. Widera, G., Burkly, L. C., Pinkert, C. A., Bottger, E. C., Cowing, C., Palmiter, R. D., Brinster, R. L. and Flavell, R. A. 1987. Transgenic mice selectively lacking MHC class II (I-E) antigen expression on B cells: an in vivo approach to investigate la gene function. Cell 51:175.
47. van Ewijk, W., Ron, Y., Monaco, J., Kappler, J., Marrack, P., Lemeur, M., Gerlinger, P., Durand, B., Benoist, C. and Mathis, D. 1988. Compartmentalization of MHC class II gene expression in transgenic mice. Cell 53:357.
48. + T cells in major histocompatibility complex class II-deficient mice. J. Exp. Med. 182:993.
49. + T lymphocytes. Science 268:863.
50. Merkenschlager, M., Benoist, C. and Mathis, D. 1994. Evidence for a single-niche model of positive selection. Proc. Natl Acad. Sci. USA 91:11694.
51. + T cells, but affect their long-term life span. Immunity 5:217.
52. Rooke, R., Waltzinger, C., Benoist, C. and Mathis, D. 1997. Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses. Immunity 7:123.
53. Brocker, T. 1997. Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J. Exp. Med. 186:1223.
54. de Preval, C., Lisowska-Grospierre, B., Loche, M., Griscelli, C. and Mach, B. 1985. A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature 318:291.
55. Plaeger-Marshall, S., Haas, A., Clement, L. T., Giorgi, J. V., Chen, I. S., Quan, S. G., Gatti, R. A. and Stiehm, E. R. 1988. Interferon-induced expression of class II major histocompatibility antigens in the major histocompatibility complex (MHC) class II deficiency syndrome. J. Clin. Immunol. 8:285.
56. Hume, C., Shookster, L., Collins, N., O'Reilly, R. and Lee, J. 1989. Bare lymphocyte syndrome: altered HLA class II expression in B cell lines derived from two patients. Hum. Immunol. 25:1.
57. Griscelli, C., Lisowska-Grospierre, B. and Mach, B. 1989. Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic. Rev. 1:135
58. Schuurman, H. J., van de Wijngaert, F. R. Huber, J., Schuurman, R. K., Zegers, B. J., Roord, J. J. and Kater, L. 1985. The thymus in 'bare lymphocyte' syndrome: significance of expression of major histocompatibility complex antigens on thymic epithelial cells in intrathymic T-cell maturation. Hum. Immunol. 13:69.
59. Lambert, M., van Eggermond, M. C., Kraakman, M. E., Schuurman, R. K. and van den Elsen, P. J. 1990. The MHC class II deficiency syndrome: heterogeneity at the level of the response to 5-azadeoxycytidine. Res. Immunol. 141:129.
60. van Eggermond, M., Rijkers, G., Knis, W., Zegers, B. and van der Elsen, P. 1993. T cell development in a major histocompatibility complex class II-deficient patient. Eur J. Immunol. 23:2585.
61. Rieux-Laucat, F., Le Deist, F., Selz, F., Fischer, A. and de Villartay, J. P. 1993. Normal T cell receptor V beta usage in a primary immunodeficiency associated with HLA class II deficiency. Eur. J. Immunol. 23:928.
62. - population with altered physicochemical properties of complementarity-determining region 3. J. Immunol. 156:895.
63. Smith, C., Bremard-Oury, C., Deist, F. L., Griscelli, C., Aucouturier, P., Moller, G., Hammarstrom, L., Preud'homme, J. and Weening, R. 1988. The antibody spectrum in individuals with defect expression of HLA class II and the LRA-1 glycoprotein family genes. Clin. Exp. Immunol. 74:449.
64. Griscelli, C., Fischer, A., Grospierre, B., et al. 1984 Clinical and immunological aspects of combined immunodeficiency with defective expression of HLA antigens. Progr. Immunodefic. Res. Ther. 1:19.
65. Hadam, M. R., Dopfer, R., Dammer, G., Derau, C. and Niethammer, D. 1986. Expression of MHC antigens in MHC class II deficiency. Progr. Immunodefic. Res. Ther. 1:89.